Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CNXC | OPRA |
|---|---|---|
| Price | $25.87 | $17.71 |
| Change today | ▲ 3.85% | ▲ 0.06% |
| Market cap | $1.58B | $1.57B |
| Return, 3 months | +15.1% | -10.0% |
| Return, year to date | -35.3% | +31.1% |
| Return, 1 year | -43.0% | +3.5% |
| P/E (TTM) | -0.7 | 12.8 |
| P/B | 0.9 | 1.6 |
| P/E percentile vs own 5y | 17th | – |
| Dividend yield | 5.57% | 6.78% |
| Revenue growth (YoY, latest qtr) | – | +24.6% |
| Net profit growth (YoY) | – | +75.7% |
| Gross margin | – | 62.1% |
| Operating margin | – | 16.4% |
| Net margin | – | 15.5% |
| Return on equity | – | – |
| Analyst target vs. price | +34.0% | +51.5% |
| Analyst buy share | 67% | 100% |
| RSI (14) | 45 | 41 |
| 30-day volatility | 78.5% | 22.5% |
| Max drawdown, 1 year | -61.1% | -41.3% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
